Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  124 results for ""Kircik, L.""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*.

Subjects: ATOPIC dermatitis; DRUG efficacy; QUALITY of life

  • Source: British Journal of Dermatology. Mar2021, Vol. 184 Issue 3, p437-449. 13p.

  • Abstract: Summary: Background: Tralokinumab, a fully human monoclonal antibody, specifically neutralizes interleukin‐13, a key cytokine driving peripheral inflammation in atopic dermatitis (AD). In phase II studies, ...

Record details

×
Academic Journal

Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials.

Subjects: PSORIASIS; INTERLEUKIN-17; RECEPTOR antibodies

  • Source: Journal of the European Academy of Dermatology & Venereology; Aug2018, Vol. 32 Issue 8, p1305-1313, 9p

  • Abstract: Background Patients with psoriasis have lesional symptoms, including itch, which can reduce quality of life. The efficacy and safety of brodalumab, an interleukin-17 receptor A ... Copyright of Journal of the European Academy of Dermatology & Venereology is the property of Wiley-Blackwell and its content may not be copied or emailed ...

Record details

×
Academic Journal

Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis.

Subjects: PSORIASIS; JANUS kinases; QUALITY of life

  • Source: Journal of the European Academy of Dermatology & Venereology; Feb2017, Vol. 31 Issue 2, p323-332, 10p

  • Abstract: Background Tofacitinib is an oral Janus kinase inhibitor being investigated for psoriasis. A Phase 3 withdrawal/re-treatment study ( NCT01186744; OPT Retreatment) showed tofacitinib re-treatment was effective ... Copyright of Journal of the European Academy of Dermatology & Venereology is the property of Wiley-Blackwell and its content may not be copied or emailed ...

Record details

×
Periodical

Readers want to know.

  • Source: Bottom Line Health (BOTTOM LINE HEALTH), 2006 Jun; 20(6): 16-16. (1p)

Record details

×
Academic Journal

Secukinumab improves the signs and symptoms of moderate-to-severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double-blind, placebo-controlled, phase 2 dose-ranging study.

Subjects: PSORIASIS; PSORIASIS treatment; PATIENTS

  • Source: Journal of the European Academy of Dermatology & Venereology; Aug2014, Vol. 28 Issue 8, p1127-1129, 3p

  • Abstract: A letter to the editor is presented in response to the article " A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients" published in ...

Record details

×
Academic Journal

Research abstracts presented at the Western Society of Allergy, Asthma, and Immunology Meeting, January 24-28, 2010.

Subjects: ABSTRACTS; ASTHMA; IMMUNOLOGY

  • Source: Allergy & Asthma Proceedings; Mar/Apr2010, Vol. 31 Issue 2, p165-167, 3p

  • Abstract: This section presents abstracts of papers presented at the Western Society of Allergy, Asthma, and Immunology Meeting held on January 24-28, 2010, including "Safety and Efficacy ...

Record details

×
  • 1-10 of  124 results for ""Kircik, L.""